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ABSTRACT 
English 
Introduction: Cardiovascular disease (CVD) accounted for 30% of an estimated 58 million 
death globally from all causes in 2005 and death due to non-communicable disease (half from 
CVD)  is expected to increase by 17% from 2006 to 2015 (1).  
 
Objective: To evaluate patient satisfaction, modifiable cardiovascular risk factors and their 
relationship after 6 months follow up among moderately-high cardiovascular risk patient 
attending Klinik Rawatan Keluarga (KRK), Hospital Universiti Sains Malaysia (USM) . 
  
Material and method: A cross sectional study and prospective study was conducted among 
patient with moderately-high cardiovascular (CV) risk patient attending KRK, USM hospital, 
Kelantan. Patient with moderately-high CV risk underwent structured counseling on CV risk 
prevention and their satisfaction to the doctor-patient interaction was assessed using SKIP 11,  
patient was also assessed on their modifiable CV risk (SBP, TC & HDL) at baseline and at 6 
months post counseling to see the changes in the outcome. The association between satisfaction 
and outcome were evaluated. Descriptive analysis, paired t test and general linear regression 
were used using PASW version 19. 
 
Result:  A total of 104 patients responded giving a response rate of 98.1%.  76.5% of the patient 
was satisfied with doctor-patient interaction with the favorable domain of distress relief (85.3%) 
and rapport (91.2%). The unfavorable domain was interaction outcome with only 67.6% patient 
satisfied in this domain. There were also significant changes in the modifiable CV risk namely 
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total cholesterol (TC) p<0.022 and systolic blood pressure (SBP) p<0.001 after 6 months post 
intervention counselling. However, there was no relationship between patient satisfaction and 
changes in modifiable cardiovascular risk. 
 
Conclusion: With the use of structured cardiovascular risk prevention counseling based on 
WHO (2007) guideline, majority (three quarter) of moderately-high risk CV patients showed 
satisfaction in doctor-patient interaction, specifically in terms of distress relief and rapport. Even 
though there is improvement in the modifiable risk factors namely SBP and TC at 6 months 
follow-up, however this changes were not related with the patients’ satisfaction. It can be 
concluded that the improvement of modifiable CV risk factors studied do not solely result from 
single intervention counselling but can be contributed by many factors such as content of 
intervention counselling, drug dosage adjustment, frequent medical visit and compliance intent.  
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ABSTRAK 
Bahasa Melayu 
Pengenalan: Penyakit Kardiovaskular adalah penyebab kepada 30% kematian yang dianggarkan 
di dalam 58 juta kematian dunia daripada semua penyebab pada tahun 2005. Kematian kerana 
penyakit tidak berjangkit ini (separuh daripadanya adalah kardiovaskular) di jangka akan 
meningkat dari 17% dari tahun 2006 hingga 2015 (1) 
 
Objektif:  Untuk menilai kepuasan pesakit , risiko kardiovaskular yang boleh diubah dan 
hubung kait diantaranya selepas 6 bulan rawatan susulan dalam kalangan pesakit yang 
mempunyai faktor risiko sederhana-tinggi di Klinik Kesihatan Keluarga, Hospital Universiti 
Sains Malaysia (USM). 
 
Bahan dan Kaedah: Satu kajian hirisan lintang dan kajian prospektif  (kehadapan) telah 
dilakukan di kalangan pesakit-pesakit yang mempunyai risiko kardiovaskular sederhana-tinggi 
yang menghadiri Klinik Rawatan Keluarga, Hospital USM, Kelantan. Pesakit–pesakit ini akan di 
beri kaunseling mengenai cara-cara mencegah penyakit kardiovaskular. Kemudian tahap 
kepuasan pesakit terhadap interaksi antara doktor dan pesakit di nilai melalui soalan daripada 
SKIP 11.Pesakit juga akan dinilai kadar perubahan faktor risiko (TC, HDL dan SBP) selepas 
enam bulan kaunseling. Hubungkait diantara nilai-nilai ini akan diukur melalui analisa deskriptif,   
t-berkembar dan regresi linear umum mengunakan PASW 19. 
 
Keputusan: Seramai 104 orang pesakit bertindak memberi kadar respon 98.1%. 76.5% pesakit 
berpuas hati dengan interaksi  di antara doktor dan pesakit, dengan domain yang disukai lega 
 
 
x 
 
tekanan (85.3%) dan domain hubung baik (91.2%).Domain yang kurang diminati ialah domain 
hasil interaksi (67.6%). Terdapat juga perubahan yang positif selepas 6 bulan di dalam faktor 
risiko boleh ubah seperti perubahan dalam tahap kolesterol dan tekanan darah sistolik. Tetapi 
tiada perkaitan di antara kepuasan pesakit dan perubahan nilai faktor risiko. 
 
Kesimpulan: ¾ daripada pesakit kategori sederhana-tinggi risiko CV, berpuashati dengan 
interaksi diantara doktor dan pesakit terutama di dalam domain hubung baik dan lega tekanan 
selepas sesi kaunseling intervensi.  Walaupun terdapat perubahan yang baik dalam faktor risiko 
boleh ubah seperti SBP dan TC selepas enam bulan, tetapi perubahan ini tidak berkait dengan 
kepuasan pesakit. Dapat disimpulkan bahawa perubahan baik dalam faktor risiko CV tidak hanya 
bergantung kepada satu kaunseling ini sahaja tetapi ia juga boleh disebabkan oleh perubahan 
dalam dos ubat, kekerapan rawatan susulan dan kesanggupan pesakit untuk patuh kepada arahan.
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CHAPTER 1 
INTRODUCTION 
 
Cardiovascular disease (CVD) accounted for 30% of an estimated 58 million deaths globally 
from all causes in 2005 (1) and between 2006 and 2015, deaths due to non-communicable 
diseases (half of which will be due to CVD) are expected to increase by 17% (1).  
 
According to data from the Information and Documentation System Unit of the Ministry of 
Health of Malaysia showed that CVD had been the main cause of death in government hospitals 
over the years which accounted for 23% to 26% of deaths from 1994 to 2001. Out of this figure, 
heart disease accounted for 14% to 16.6%. (2) 
 
Cardiovascular risk is defined as probability of an individual experiencing a cardiovascular event 
over a 10-year period(3). It is important for attending physician or other health care personnel to 
identify patient with 10-year risk of coronary heart disease event in order to address the problems 
earlier and more aggressive intervention could be instituted. The used of scoring system to 
categorize patient into low, moderate, moderately-high and high risk is important for disease 
management(4). 
 
Many risk score have been implemented and used worldwide such as  Framingham Coronary 
Risk Prediction Tool (FRS),  Adult Treatment Panel (ATP) III, Framingham Risk Equations 
(FRS) 2008 risk score, the Systematic Coronary Risk Evaluations(SCORE) project, the 
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Assessing Cardiovascular Risk to Scottish Intercollegiate Guidelines Network (ASSIGN) risk 
score, the QRESEARCH cardiovascular risk algorithm (QRISK) CVD risk score, Reynolds risk 
score  for woman, Reynolds risk score for  men and World Health Organization/ International 
Hypertension Society (WHO/ISH) risk score(5, 6). Among those risk scores listed above, the 
original Framingham Risk Score and the ATP III are more or least similar.  The other risk scores 
had been modified to involve other variables and outcomes according to their research 
characteristic, interest and population studies. 
 
This study choose the traditional Framingham risk score because this score is being used 
worldwide since 1998 and being validated across population (men, women, blacks, Europe, 
Mediterranean and Asian)(5, 6). Recently, this score (using low information equations) was used 
to compare data from Framingham study with Asian cohort study on the accuracy of 
cardiovascular risk prediction resulted in similar accuracy in Asian population after recalibrated 
(7). 
 
Framingham equation in Asian study used low information equation (7), thus in this current 
study, we used the traditional Framingham equations that derived from Framingham cohort, even 
though there are existing new equations such as FRS 2008 and other equations available(5, 6) as 
listed above. To our knowledge, only the traditional FRS equation being validated across 
population(5, 6). 
 
 In addition to that, the outcome of traditional FRS equations is fatal and nonfatal Myocardial 
Infarction (CHD) but not the global cardiovascular disease as a whole including stroke, 
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peripheral arterial disease or heart failure(5, 8). Thus, this study used asymptomatic patient with 
no history of coronary heart disease or cardiac event as a participant because the predicted risk 
only applies to individual without diagnosed heart disease(8) to predict the hard end point of 
fatal and nonfatal CHD. 
 
Even though the traditional FRS had some limitations (8) as compared to other new model of 
equations(5, 6) in term of the variables and outcome measure, but the low information equations 
is suitable to be used in the outpatient clinic with limited resources and it is user friendly 
whereby the equations does not need high information such as C-peptide or C reactive protein 
and it is easy to calculate and efficient because it only has 5 risks in the equations. The used of 
equations that need the measurement of C reactive protein example Reynolds CAD risk is not 
suitable to be used in center with limited resources(6). Besides that, the FRS equations also had a 
wide range of age, from 20 years old to 79 years old both in men and women as compared to 
FRS (2008). The FRS (2008) starting age is 30 years old up to 75 years old in both men and 
women(9).  
 
The  variable in the traditional FRS are sex, age, systolic blood pressure treated or untreated, 
total cholesterol, high density lipoprotein and smoking status(8). This FRS is not originally 
designed for use in diabetic populations. The cohort that was originally used to derive this 
equation included relatively few diabetic patients, specifically 4% of 5573 participants from a 
restricted age range(8). Thus, the prediction with the original FRS equations is less precise in this 
population. 
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Up to year 2010, there is no consensus as to which is the best risk assessment tools to follow and 
to use for risk stratification in Asian population as there were many calculator or risk chart being 
produced worldwide(5, 6, 10) Ideally, each country should have its own risk score that takes into 
account other factors as well(5). 
 
The role of diabetes as a prediction of cardiovascular disease also became a major interest in 
many physicians and researchers(4). The labeling of ‘diabetes’ as a CHD risk equivalent also 
become a popular hypothesis(4). However, a meta-analysis done in year 2009 did not support the 
hypothesis that diabetes is a ‘coronary heart disease equivalent’. Patients with diabetes without 
prior myocardial infarction have a 43% lower risk of developing total CHD events compared 
with patients without diabetes with previous myocardial infarction(11).  
 
It doesn’t matter which calculation being used to predict cardiovascular risk. However, it is 
worthwhile to be familiar with one of these scores, select one that is most appropriate for the 
patient and discuss treatment options based on the estimated risk(5). The risk score is only an 
assessment tool to help us as a physician to start treatment and to counsel patient. The most 
important is the assessment of the patient as a whole including history, physical examination and 
if available biochemical test. We must not depend totally on this calculator or risk prediction 
chart alone to decide our management and need to weigh between risk and benefit of medication 
stated for primary prevention (4, 5, 8, 11).  
 
In addition to that, since diabetes is not a coronary heart disease risk equivalent(11), we should 
not treat diabetes patient as  a primary prevention(11), for example starting all diabetes patients 
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with aspirin without their estimated global CHD risk. Public health decisions to initiate cardio-
protective drugs in patients with diabetes for primary CHD prevention should therefore be based 
on appropriate patients’ CHD risk estimates rather than a ‘blanket’ approach of treatment(11). 
 
The other study also showed that expensive testing of biomarkers such as coronary calcium score 
and C-reactive protein can improve risk estimation, but the evidence on outcome improvement 
are lacking. Another example is the use of sophisticated risk identification by using nuclear 
stress imaging to screen patient for coronary heart disease.  Patients who were screened did not 
have significantly fewer cardiac events compared with those who were not screened(12). Thus, 
the prediction tools only help us to guide our management. There is no guarantee that the 
expensive tools will result in good outcome. The most important is how clinicians make use of it 
in daily clinic visit and at the same time helping patient to reduce their cardiovascular risk. 
 
Nowadays, patient preferences for disease management are increasingly important and there 
should be shared decision making in which both patient and physician are equally and actively 
involved and share information in order to reach an agreement(13). Patient satisfaction with 
doctor-patient interaction also influences the outcomes of the physician-patient discussion(14). 
Hence, it is important to measure patient satisfaction. A high satisfaction with physician-patient 
interaction is associated with increased adherence, better continuity of care, treatment decisions 
and even positive adjustment (15).  
 
To measure satisfaction, there are two validated questionnaire being used that are the Medical 
Interview Satisfaction Scale (MISS) and the Consultation Satisfaction Questionnaire (CSQ). 
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However, MISS measure humanness more consistent than CSQ(16). In addition to that, MISS 
had been translated to Malay version and being validated to be used in Malaysia and known as 
Skala Kepuasan Interaksi Perubatan (SKIP)(17). 
 
According to Peter Ham , there is no studies showing that coronary heart disease risk calculation 
alone changes outcome and this suggests that the physician-patient interaction is more important. 
The systematic review of coronary heart disease showed that the quality of educational 
interventions can result in improvement in risk and compliance(12). However, there is no 
specific module or decision aids had been used to guide the counseling on cardiovascular risk in 
Klinik Rawatan Keluarga (KRK) in the current practice. The counseling depends on physicians’ 
style and knowledge to counsel patient. 
 
1.1 Justification of the study 
 
In Malaysia, cardiovascular disease has become a burden and the leading cause of death both in 
men and women. There is also very few studies in Malaysia that described our population 10-
year CHD risk and address the necessary intervention (18-20).  
 
There is strong evidence from clinical tools that reducing the levels of risk factors has beneficial 
effect on CHD and CVD. Thus, risk factor screening and management have now been widely 
used in cardiovascular prevention guideline in most high income countries(3, 21).  
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The 10-year risk using Framingham risk score has divided the person into mild, moderate, 
moderately-high and high risk group(4). The high risk group may have already experienced a 
coronary heart disease event and risk stratification is not necessary for making treatment 
decisions for these individuals because all of them need intensive lifestyle interventions and 
appropriate drug therapy(3).  In addition to this, almost all asymptomatic individual with 0-1 risk 
factor have a 10-year risk < 10%, thus 10-year risk assessment is not necessary(4).  
 
Thus, risk stratification is important for asymptomatic patient with two or more risk factors to 
enable the intensity of intervention to be matched with the degree of total risk(3, 5). 10-year risk 
stratification using traditional Framingham risk score can give prediction to the probability of 
this patient developed fatal and nonfatal CHD event in next 10 years(8). Patient with 2 or more 
risk factor can fall into moderate CHD risk (<10%) and also moderately-high CHD risk (10-
20%)(4). Hence, this study will focus on patients with 10-year CHD risk of 10-20% (moderately-
high) in view of the probability for fatal or non-fatal events and higher probability of getting 
changes in the outcome parameters of interest within the specific period of time.  
 
In this study, we are focusing on a counselling related to risk stratification approach to guide us 
in prevention of cardiovascular event. This is a preliminary study of patient satisfaction on 
doctor-patient interaction on cardiovascular disease risk prevention in ordinary setting. It helps to 
assess whether the risk stratification approaches(3) will be able to motivate patients, particularly 
to change behavior and when appropriate, to take antihypertensive and lipid-lowering drugs.  
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Patient satisfaction influences the outcomes of the doctor-patient encounter(14) and a high 
satisfaction will lead to increase adherence and even positive adjustment of the patients(15). 
Hence, studying the local setting is important for identifying rooms of improvement and the 
possibility of intervention in the future. This is because there is no standard module or decision 
aids had been used for counseling on cardiovascular risk in KRK, Hospital USM. 
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CHAPTER 2 
LITERATURE REVIEWS 
 
2.1 Cardiovascular disease 
Population wide public health approaches alone will not have an immediate tangible impact on 
cardiovascular morbidity and mortality (22). A combination of population-wide strategies and 
strategies targeted at high risk individuals is needed to reduce the cardiovascular disease burden. 
The extent to which one strategy should be emphasized depends on achievable effectiveness, 
cost-effectiveness and availability of resources (1, 22-24). 
 
Determining a patient’s global coronary heart disease (CHD) risk may improve appropriate 
prescribing (12). A 2003 study of six subspecialists in diabetes and 323 patients found a non-
significant trend toward increased overall prescribing of cardiovascular drugs (25). In a high-risk 
subset of these patients, physicians prescribed significantly more blood pressure and lipid 
lowering medications when the global CHD risk score was known (25). This is a promising 
example of behavior change among physicians. However, changing physicians’ intent to 
prescribe does not guarantee improved outcomes. For example, a study of patients with 
hypertension found that physicians who were given charts to calculate CHD risk prescribed more 
antihypertensive drugs (resulting in a reduction of 4.6 mm Hg in systolic blood pressure) but the 
overall risk of cardiac events did not change (26). Identifying risk and doing something about it 
are two distinct entities(12).  
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2.2 Patient Satisfaction 
Patient satisfaction influences the outcomes of the physician-patient encounter(14). For every 
patient, a medical consultation forms part of a continuing process of coping with illness. Patients 
have expectations when they visit their doctors and the degree to which these expectations are 
met influences satisfaction (14). A high satisfaction with physician-patient interaction is 
associated with increased adherence, better continuity of care, client participation in important 
treatment decisions and even beneficial/positive adjustment (15).  
 
The role of the patient in healthcare decision making has changed. There is a trend towards 
greater involvement by patients in their personal healthcare management. Patient preferences for 
disease management are considered increasingly important and some feel they should influence 
individual decision-making (13). Shared decision making is particularly important with regard to 
CVD prevention. Physicians are not only expected to inform and involve their patients in CVD 
prevention but the focus is also shifting from individual risk factors, such as hypertension or 
hyperlipidemia alone to global risk (multiple risk factor) as a guide for preventive action (27). 
  
2.3 Patient Satisfaction Questionnaire 
The consultation is the central act of medicine. There are different tools of questionnaire to 
measure consultation outcome.  The consultation outcomes can be divided into symptoms relief, 
diseases control, enablement, general health, compliance or adherence, efficiency, satisfaction 
and also quality of consultation(28).  
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As an example, Patient Enablement Instrument is used to assess patient ability to understand the 
illness and coping with symptoms. This is usually used in patient centered assessment because it 
measures immediate effect to the current enablement(28).  Patient Enablement Questionnaire had 
been compared with MISS and CSQ to see their correlation and the result showed that although  
enablement is an outcome of the consultation but it was different from MISS and CSQ and 
cannot be used to measure satisfaction (29).  
 
For the general health, an example of the questionnaires is the Medical Outcome Study 11 and 
“Eurocol 5 dimension”. These questionnaires are used to grade the patient’s general health. The 
three quality instruments are Europep, Improving Practice Questionnaire (IPQ) and General 
Practice Assessment Questionnaire (GPAQ)(28, 30). The Europep instrument has been used for 
evaluation of care and for evaluation of the General Practitioners, for comparison between health 
care in different countries and for comparison between health care systems in different countries 
and other studies(28). IPQ and GPAQ Questionnaire measures opinion of the patient towards   
GP service as used in UK (28, 31). Shared Decision Making Questionnaire (SDM-Q) is used in 
studies investigating the effectiveness of SDM and as a quality indication in health. It aims in 
assessing the decision process (32). 
 
To measure satisfaction there are two tools that are validated and reliable, The Consultation 
Satisfaction Questionnaire (CSQ) and Medical Interview Satisfaction Scale (MISS)(16, 28). 
These two questionnaires measure satisfaction with different aspect of doctor performance. CSQ 
was developed by Baker (33) and used in British General Practice whereas MISS was originally 
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elaborated in USA as MISS 29 but it was adapted to English Standard version which known as 
MISS-21. Both of these questionnaires are validated and reliable (16) 
 
The 29-item Medical Interview Satisfaction Scale (MISS-29) was developed to assess patient 
satisfaction with individual doctor-patient satisfaction with four subscales and patients were 
asked to indicate their level of agreement on a seven-point Likert scale(34)    
 
A modified MISS-21 with the same four original subscales was produced and tested in a wider 
UK general practice population. Correlation between subscales ranged from 0.46 to 0.65. Values 
of Cronbach’s alpha ranged between 0.67 and 0.92 (35). 
 
Most of the surveys had focused on general evaluations of doctor and/or health care service. 
Only a few have shown evidence of careful methodology. Methods of item generation and 
pretesting in the MISS-26 are detailed. The overall reliability of the scale (Cronbach’s coefficient 
alpha) is 0.93. The distribution of satisfaction scores is broader than that reported for other scales 
and approaches the normal in shape. It is internally consistent, easily administered measure of 
three aspects of patient satisfaction; cognitive, affective and behavioral. Correlations of the scale 
with socio demographic variables are low or no significant, which suggests that these factors do 
not seriously contaminate responses(34). 
 
The second study comparing MISS 29 and CSQ was done by Kinnersley.P, Nigel (16) showed 
that both questionnaires were not superior than another in psychometric term. Both have high 
level of internal consistency. However MISS measure humanness more consistent than CSQ. A 
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third study done by Meakin and Weinman (35) in British General Practice using MISS-29 to 
measure validity, reliability and applicability of MISS-29 in British General Practice population 
resulted in the development of a new 21-item version with the same four subscales as the 29-item 
MISS which has satisfactory internal reliability. The correlations between subscales suggest that 
they represent fairly discrete but overlapping aspect of satisfaction. Evidence produced 
suggesting that patients have less difficulty completing the MISS-21. It is a valid and reliable 
instrument for the assessment of patient satisfaction with individual consultation. 
 
The MISS-21 questionnaire also being used in cross sectional study in Nigeria (14) to measure 
patient satisfaction. Other studies that assessed patient satisfaction in out-patient clinic were a 
study in Trinidad and Tobago(36) and in Netherland(37). A modified version of MISS-21 
adapted to Nigerian population consists of statements to which patients indicate their level of 
agreement on a five-point Likert scale of responses. The original MISS-21 was pretested and the 
items were reduced from seven to a five-point scale (14) 
 
SKIP-11 is the validated Malay version questionnaire originated from Medical Interview 
Satisfaction Scale (MISS). It can be used to assess patient satisfaction on patient-physician 
interaction in primary health care setting because it is acceptably valid, reliable and simple(17) 
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2.4 Framingham Coronary Heart Disease Risk Prediction Score (FRS) 
The Framingham Risk Assessment tools have been used extensively with men and women and 
with a number of ethnic groups. They are considered the “gold standard” for risk assessment 
(38). Risk factors used in Framingham scoring include age, total cholesterol, high density 
lipoprotein cholesterol,  blood pressure and cigarette smoking and divides persons with multiple 
risk factors into those with 10-year risk for CHD of >20%, 10-20%, and <10% (39). 
Cardiovascular risk equations are traditionally derived from the Framingham Study (1948). Risk 
scores have different accuracy in different populations, tending to over predict in low-risk 
populations and under predict in high-risk populations. Risk scores using the Framingham 
equations have been widely tested in North American and European populations of European 
origin (40-43) and validated in a Chinese population (44) but not in other populations.  
 
Framingham risk equation systematically overestimated risk in the Chinese cohorts by an 
average of 276% among men and 102% among women. The corresponding average 
overestimation using the Asian cohort equation was 11% and 10%, respectively. Recalibrating 
the Framingham risk equation using cardiovascular disease incidence from the non-Chinese 
Asian cohorts led to an overestimation of risk by an average of 4% in women and 
underestimation of risk by an average of 2% in men (7). Despite these quantitative differences in 
the HRs for the associations between certain risk factors (total cholesterol and SBP) the risk 
equations from the Framingham and the Asian cohorts ranked individual risk similarly, resulting 
in comparable, good cardiovascular risk discrimination. This indicates that, qualitatively, the 
major determinants of cardiovascular risk are broadly similar, and act similarly, across 
populations that such differences may not be of major practical importance in risk prediction (7). 
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 One study to find the accuracy and utility of the FRS was done in University of Malaya (18) 
using retrospective cohort of 600 patients attending the Family Clinic from year of 1997 and the 
event of CHD were captured up to 10 years from the baseline year. The FRS was calculated and 
they were divided into 3 CHD risk groups ie low (<10%) medium (10-20%) and high (>20%). 
The number of observed CHD events over a 10-year period was 7%, 15% and 19% for the low, 
medium and high risk group respectively. This showed that FRS accurately estimate 10-year risk 
of CHD in low and moderately high risk patient and marginally lower for the high risk group. 
The study in Kuala Langat(20) also used this FRS as their tool. 
  
In year 2010, the data from semirural area in Kuala Langat was used to see the accuracy of FRS 
and new FRS (2008)(9) and the comparison was made. The FRS (2008) was found to 
overestimate patient in this community. The distribution of the different risk categories changed 
from 14.9% to 11.8% for low, 48.5%  to 24.5% for medium and 36.6%  to 63.7% for high risk 
based on the CHD and CVD scores respectively (19).   
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Table 1.0  ATP III LDL-C Goals and Cut points for TLC and Drug Therapy in Different Risk 
Categories and Proposed Modifications Based on  Recent Clinical Trial Evidence(4)  
 
 
ATP III guideline identified diabetes as a high-risk condition. This designation was based on 
evidence that the majority of patients with ‘diabetes’ in ‘higher-risk populations’ have a 
relatively high 10-year risk for developing CVD. In addition to that, the onset of CVD in patients 
with diabetes carries a poor prognosis, both at the time of an acute CVD event and in the post-
event period(4).  
 
The conclusion made by ATP III committee to label ‘diabetes’ as a high risk because most 
patients with type 2 diabetes, are older and have multiple risk factors. Epidemiological studies 
and clinical trials demonstrate that in ‘higher-risk populations’ these patients have a risk for 
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CVD events approximately equal to that of non-diabetic patients with established CVD.  Heart 
Protection Study data found both a high risk in this group and benefit from LDL-lowering 
therapy, supporting the LDL-C goal of <100mg/dl(4).  
 
On the other hand, in those diabetic patients without CVD who had an LDL-C at baseline of 
<116 mg/dl, risk reduction accompanying statin therapy was only marginally significant for first 
coronary event. Thus, whether to start an LDL-lowering drug when LDL-C is <100 mg/dL in 
this category of patient must be left to clinical judgment(4). 
 
Besides that, a portion of patients with diabetes can be considered to be at only moderately high 
risk because of young age or lack of other risk factors. Such patients were not studied in Heart 
Protection Study. For the category of moderately high risk (10-year risks 10% to 20%), ATP III 
guidelines favored institution of LDL-lowering drugs along with dietary therapy when LDL-C 
levels are >130 mg/dl. Thus, if a patient with diabetes is considered to be at lower risk, an LDL-
lowering drug might not be started if the LDL-C level is < 130 mg/dl. Maximal TLC clearly is 
indicated but clinical judgment must be exercised with regard to when to initiate an LDL-
lowering drug(4). 
 
 Although, ‘ATP III’ had suggested ‘diabetic’ as a ‘high risk ‘patient or ‘CVD equivalent’, but 
we must correlate it with our clinical judgment. Hence, not all patients with diabetic may need to 
be started on aspirin or high intensity statin. According to Diabetes Malaysian guideline, newly 
diagnosed patient needs to be screened with FRS or SCORE to estimate the risk for CHD 
because diabetes increased risk 2-3 fold from normal population to developed CVD. Treatment 
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with statin should be started in diabetic patient more than 40 years old regardless of their 
baseline lipid and aspirin is not recommended as a primary prevention in all diabetic patients 
without CVD unless low dose aspirin for patient above 65 years old(45). 
 
A few studies had being conduct following the labeling of diabetes as CHD risk equivalent to see 
the accuracy of the hypothesis in their population. As an example, a study regarding the 
influence of single and multiple risk factors on the 10-year cumulative incidence of fatal and 
nonfatal CHD and cardiovascular disease (CVD) in diabetic and non-diabetic men and women, 
with and without baseline CHD or CVD, in a population (n= 4,549) with a high prevalence of 
diabetes was done. The conclusion in this study after comparable was made from previous study   
showed that wide variation in the rate of CHD in diabetes, depending on the population and 
existing risk factors. The cumulative incidence in individuals had been variable and some of 
them had risk >20%, but only those with multiple risk factors had a 10-year cumulative 
incidence that was equivalent to that of patients with CHD.  The author in this study suggested  
that until more data are available, it may be prudent to consider targets based on the entire risk 
factor profile rather than just the presence of diabetes alone(46). 
 
This study was further supported by a meta-analysis done in year 2009. This meta-analysis did 
not support the hypothesis that diabetes is a ‘coronary heart disease equivalent’. Patients with 
diabetes without prior myocardial infarction have a 43% lower risk of developing total CHD 
events compared with patients without diabetes with previous myocardial infarction (11) 
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In Malaysia, a study on CVD risk of a semirural community over the age of 55 years old (mean 
age of 65)  in Kuala Langat using FRS score found a total of 40.5% of  men had 10-20% risk of 
having a CHD event in the next 10 years whereas women with 10-20% risk is  51.4%. The 
percentage of moderately-high CHD risk in both sexes is almost equally distributed. However,  
55.8% of the men had >20% risk of having a CHD event in the next 10 years compared to 
women’s with only 15.1% having a risk of ≥20%. Demographics data of both women and men in 
this study were almost similar except for the men who smoke is 54.2% whereas women who 
smoke are only 11%. Smoking may contribute to the discrepancy between men and women in 
the high risk categorized(20). This study showed that the distribution of moderately-high risk 
CHD patient in our country is equally important with the high risk CHD patient for probability of 
developing CHD in next 10 year. An attempt to address the important of this group in CVD 
prevention is needed. 
 
This also supported by study done among low-income urban dwellers of metropolitan in 
Malaysia where the prevalence of moderately-high (7-20%) risk patients were almost equal both 
in men (43%) and women (34%) with the mean age of 44 years old. However, in the high risk 
group, the prevalence was more in men (35%) as compared to women (11.6%) (47). Although, 
they took diabetes, hypertension and smoking as one of the demographic data in their method, 
but they did not presented it in their result. In addition to this, they also compared FRS score 
with FRS (2008) modified version using BMI as replacement for TC/HDL model. Both score did 
not have significant different. However, need to take note that their cutoff score between low and 
moderate is 7% and not 10%. 
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The low income community in metropolitan (Kuala Lumpur)(47) also similar with community in 
semirural area in Kuala Langat(20) whereby men and women in the moderately-high CHD  had 
similar demographic profile to develop CHD in next ten years. Thus, this supported our 
justification to do prevention of cardiovascular disease counseling in moderately-high CHD risk 
patient in our clinic. 
 
Recent study (48) regarding cardiovascular risk in KRK also supported the finding of above 
study whereby the prevalence of patient attending KRK was 32.7% belonged to moderately high 
risk, another 36.2% belonged to high risk patient and 31.1% belonged to low risk according to 
FRS and their mean age was 55 years old,  the percentage of patients with diabetes were 31.6% 
and smoker 7.7%(48). This showed that there was equal distribution between high risk, 
moderately-high and low risk in KRK, Kelantan(48) where majority of the patient were non-
smokers. This was also similar with population in Kuala Langat where the total risk score (men 
and women)  was low risk 18.6%, moderately-high risk 46% and high risk 35.4%(20). The total 
risk score for (men and women) in low income metropolitan of Kuala Lumpur were 38.8% of 
low risk, moderately-high risk was 38.5% and high risk was 23.3%(47).  
 
 According to the Third National Health and Morbidity Survey in 2006, only 19.7% were aware 
of their hypercholesterolemia state and from these, only 44.1% were on treatment. However, 
only 69% were controlled. Awareness among the hypertensive patients have changed very little 
over the years i.e. 33%, 35.8% in 1996, 2006 respectively. However, only 23% of those who 
were aware received treatment in 1996 but it has increased to 87.7% in 2006 (49, 50). 
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The NHMS III survey had almost similar with population study in Kuala Langat. The mean 
systolic BP is in the stage I hypertensive range. More than half of the participants were 
hypertensive, of whom only 18.8% were reported and the remaining 33.5% were undiagnosed. 
This was again similar with hypercholesterolemia, where more than half have total serum 
cholesterol of greater than the desired upper limit of 5.2mmol/l. Nearly two thirds of the subjects 
have LDL-cholesterol levels ≥3.4mmol/l and about a third have low HDL-cholesterol. They 
remain unaware of their status(20). 
 
 
In patients with a systolic blood pressure above 150 mmHg, or a diastolic pressure above 90 
mmHg, or a blood cholesterol level over 5.0mmol/l, drug treatment reduces the relative risk of 
cardiovascular events by between one-quarter and one-third. If blood pressure was reduced by 
10–15 mmHg (systolic) and 5–8 mmHg (diastolic) and blood cholesterol by about 20% through 
combined treatment with antihypertensive and statins, then cardiovascular disease morbidity and 
mortality would be reduced by up to 50% (3). Even modest reductions, such as few mmHg that 
might be expected from reducing salt intake, if applied across the population could result in 
reductions of at least a tenth in cardiovascular disease (51). People at higher CVD risk would 
benefit more, in terms of number of events avoided, because the relative risk reduction would be 
applied to a higher baseline risk (51).  
 
Therefore, targeting patients with a high risk is the first priority in a risk stratification approach. 
However, risk stratification charts are unnecessary to arrive at treatment decisions for these 
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categories of patients because they require both lifestyle and pharmacological interventions to 
help them reduce their risk and number of cardiac event(3) 
 
Thus, risk stratification is important for asymptomatic patient with moderate and moderately-
high risk CHD patient to enable the intensity of interventions to be matched to the degree of total 
risk(3). For the individual with 0 to 1 risk factor, assessment of 10-year risk using FRS is 
unnecessary since this individual usually fall into < 10 % CHD risk score(4). Although, 
cardiovascular events are less likely to occur in people with low levels of risk(3) but CHD events 
still can occur in asymptomatic people with moderate and moderately-high CHD risk group. It is 
relatively easy to identify those who are obviously at high risk and those at the lowest risk for 
CVD, it is often the large group of individuals with what appears to be modestly abnormal risk 
factors who contributes most to the burden of CVD.(5). Thus 10-year risk stratification using 
traditional Framingham risk score can give prediction to the probability of this patient developed 
fatal and nonfatal coronary heart disease event in next 10 years(8). In other words, the great 
strength of the risk scoring approach is that it provides a rational means of making decisions 
about intervening in a targeted way, thereby making best use of resources available to reduce 
cardiovascular risk (3). 
 
In the past, an approach focused on single risk factors, or concepts such as pre hypertension or 
pre diabetes have been popular. Such an approach, however, leads to a very large segment of the 
population being labeled as high risk, most of them incorrectly. If health care resources were 
allocated to such false-positive individuals, a large number of individuals with other multiple risk 
factor would remain without medical attention(3) example a man, age 45 who smoke, had low 
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HDL cholesterol of <1.1 mmol/l and TC of 5mmol/l with no hypertension (SBP of 122 mmHg) 
will be missed because this individual did not have hypertension. This patient had multiple risk 
factors (2 or more) and when calculated using FRS, his 10-year CHD risk are 12%. So it is 
important to use risk stratification to initiate treatment or guide the counselling in cardiovascular 
risk prevention.  
 
 
 
 
 
 
 
 
 
 
 
 
        
                                       Figure1. Conceptual framework 
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CHAPTER 3 
OBJECTIVES AND RESEARCH HYPOTHESES 
 
3.1 General objective 
To evaluate patient satisfaction, modifiable cardiovascular risk factors and their relationship after 
six months follow-up among moderately-high risk patients attending Klinik Rawatan Keluarga, 
USM Hospital. 
 
3.2 Specific objectives 
1. To determine patient satisfaction score on doctor-patient interaction after cardiovascular 
disease risk prevention counseling. 
2. To determine changes in modifiable cardiovascular risk factors (TC, HDL, SBP) between 
baseline and 6 month follow up. 
3. To determine the association between patient satisfaction score and changes in 
modifiable cardiovascular risk factors  (TC,HDL, SBP) among moderately-high risk 
patients attending Klinik Rawatan Keluarga, HUSM. 
 
3.3 Research hypotheses 
1. There are significant changes in modifiable cardiovascular risk factors (TC, HDL, SBP) 
after six months follow-up. 
2. There are significant association between patient satisfaction score and changes in 
modifiable cardiovascular risk factors (TC, HDL, SBP) after adjusting for socio-
